Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
E-Z-EM Canada is a specialized healthcare company focused on the development and manufacture of contrast media and delivery systems for diagnostic imaging. The company is a leading provider of barium-based contrast agents used in gastrointestinal radiography and CT scans, as well as related medical devices such as injectors and enema kits. Originally a subsidiary of the US-based E-Z-EM, Inc., the Canadian operations were integrated into Bracco Imaging following the global acquisition of the parent company. Today, E-Z-EM Canada continues to support the diagnostic imaging market with a robust portfolio of products designed to enhance the visualization of the digestive tract and other internal structures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on E-Z-EM Canada.